576 related articles for article (PubMed ID: 21537945)
21. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
[TBL] [Abstract][Full Text] [Related]
22. Use of multidetector-row computed tomography to evaluate branch duct type intraductal papillary mucinous neoplasms of the pancreas: influence on surgical decision-making.
Ishii H; Taniguchi H; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sakakura C; Sonoyama T; Otsuji E
Hepatogastroenterology; 2012 May; 59(115):884-8. PubMed ID: 22020905
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI.
Choi SY; Kim JH; Yu MH; Eun HW; Lee HK; Han JK
Abdom Radiol (NY); 2017 May; 42(5):1449-1458. PubMed ID: 28144718
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
25. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
26. Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed.
Baiocchi GL; Bertagna F; Gheza F; Grazioli L; Calanducci D; Giubbini R; Portolani N; Giulini SM
Ann Surg Oncol; 2012 Oct; 19(11):3574-80. PubMed ID: 22752369
[TBL] [Abstract][Full Text] [Related]
27. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
[TBL] [Abstract][Full Text] [Related]
30. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
31. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
32. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
33. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
[TBL] [Abstract][Full Text] [Related]
35. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
Min JH; Kim YK; Kim SK; Kim H; Ahn S
Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
[TBL] [Abstract][Full Text] [Related]
36. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
[No Abstract] [Full Text] [Related]
37. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
38. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
[TBL] [Abstract][Full Text] [Related]
39. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
[TBL] [Abstract][Full Text] [Related]
40. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers.
Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Hosoda W; Nakamura Y; Shinohara T; Yanagisawa A
Pancreas; 2013 Jul; 42(5):883-8. PubMed ID: 23508017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
